Published in Ann Clin Microbiol Antimicrob on July 12, 2017
Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis (2011) 13.18
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther (2010) 1.99
Multidrug resistant acinetobacter. J Glob Infect Dis (2010) 1.94
Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect (2014) 1.81
Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect (2013) 1.64
Disk diffusion susceptibility test development for the new glycylcycline, GAR-936. Diagn Microbiol Infect Dis (1999) 1.18
Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala. J Antimicrob Chemother (2012) 1.16
Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz J Infect Dis (2013) 1.04
Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis (2014) 0.99
Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013. Ann Clin Microbiol Antimicrob (2015) 0.90
Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob (2012) 0.88
Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010. Braz J Infect Dis (2013) 0.87
Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen. J Pathog (2016) 0.85
Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis (2008) 0.85
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program. Antimicrob Agents Chemother (2015) 0.82
Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008-2012. Results of the Study for Monitoring Antimicrobial Resistance Trends. Diagn Microbiol Infect Dis (2015) 0.81
National burden of invasive methicillin-resistant Staphylococcus aureus infection. JAMA (2014) 0.81
Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. Ann Clin Microbiol Antimicrob (2015) 0.81
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014). Int J Antimicrob Agents (2016) 0.80
Antimicrobial activity against a global collection of skin and skin structure pathogens: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2010-2014. Int J Infect Dis (2016) 0.80
The combined-disk boronic acid test as an accurate strategy for the detection of KPC carbapenemase in Central America. J Infect Dev Ctries (2016) 0.78
Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America - results of AWARE surveillance 2012. Braz J Infect Dis (2015) 0.77
Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years. Braz J Infect Dis (2016) 0.77